No articles found. Thermo Fisher Scientific K.K. did not contribute to any primary research papers from Nature Index journals in the current 12 month window. The following affiliated institutions are ...
Thermo Fisher Scientific recently received U.S. 510(k) clearance for its EXENT System, an automated analyser aimed at ...
Thermo Fisher Scientific has cleared a major regulatory hurdle in getting a new diagnostic tool for a type of blood cancer in ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (GAM) Assay**, a first-of-its-kind ...
Thermo Fisher executives explain why they bypassed Massachusetts in the search for the firm's second U.S. collaboration ...
Thermo Fisher Scientific received 510 (k) clearance from the Food and Drug Administration to market its EXENT system to aid in the diagnosis of multiple myeloma. The company's EXENT system detects and ...
Designed for routine clinical use, the system can identify M-proteins based on their molecular weight to help diagnose multiple myeloma and related disorders.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Coming off a strong third ...
Article ‘Count’ and ‘Share’ for Thermo Fisher Scientific K.K. based on listed parameters only. The articles listed below published by authors from Thermo Fisher Scientific K.K., organized by journal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback